Literature DB >> 34141381

Biochemical screening of intellectually disabled and healthy children in Punjab, Pakistan: differences in liver function test and lipid profiles.

Muhammad Wasim1,2, Haq Nawaz Khan1,2, Hina Ayesha3, Fazli Rabbi Awan1,2.   

Abstract

Objectives: Inborn errors of metabolism (IEMs) are rare genetic disorders. Generally, IEMs are untreatable; however, some IEMs causing intellectual disability are potentially treatable if diagnosed earlier. In this study, levels of some clinically important biochemical parameters in intellectually disabled children suspected for IEMs were tested to see their association with intellectual disability, which could be helpful in preliminary screening.
Methods: This comparative cross-sectional observational study was carried out from 2014 to 2017. Blood samples from 800 boys and girls (aged 4-24 years) were collected, of which 391 were healthy (IQ >90) and 409 were intellectually disabled (IQ <70) children with unknown cause. Clinically important (Liver and kidney enzymes etc.) biochemical parameters were analyzed in sera samples using commercial kits on semi-automated clinical chemistry analyzer.
Results: Serum analysis showed the levels of ALP (p < 0.00001), ASAT (p = 0.001), ALAT (p = 0.016), albumin (p < 0.001), uric acid (p < 0.001), cholesterol (p < 0.001), triglycerides (p < 0.001), and hemoglobin (p = 0.005) were significantly different between healthy and intellectually disabled children.
Conclusion: Changes in the liver function test and lipid profile parameters were significantly different in children with intellectual disability; however, it requires further detailed analysis for complete characterization of these diseases.
© 2019 The British Society of Developmental Disabilities.

Entities:  

Keywords:  Intellectual disability (ID); hyperlipidemia; inborn errors of metabolisms (IEMs); liver function test; newborn screening (NBS)

Year:  2019        PMID: 34141381      PMCID: PMC8142844          DOI: 10.1080/20473869.2018.1533084

Source DB:  PubMed          Journal:  Int J Dev Disabil        ISSN: 2047-3869


  32 in total

1.  Newborn screening of metabolic disorders.

Authors:  Maria Arélin; Skadi Beblo
Journal:  J Pediatr Endocrinol Metab       Date:  2016-01       Impact factor: 1.634

2.  The development and organization of newborn screening programs in Turkey.

Authors:  Başak Tezel; Dilek Dilli; Hilal Bolat; Hatice Sahman; Sema Ozbaş; Deniz Acıcan; Mustafa Ertek; Mehmet Rıfat Köse; Uğur Dilmen
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

3.  Clinical features and genotyping of patients with primary carnitine deficiency identified by newborn screening.

Authors:  Yun Sun; Yan-Yun Wang; Tao Jiang
Journal:  J Pediatr Endocrinol Metab       Date:  2017-08-28       Impact factor: 1.634

4.  Cost-effectiveness of expanded newborn screening in Texas.

Authors:  Simrandeep K Tiwana; Karen L Rascati; Haesuk Park
Journal:  Value Health       Date:  2012-06-07       Impact factor: 5.725

5.  The organisation of training for laboratory scientists in inherited metabolic disease, newborn screening and paediatric clinical chemistry.

Authors:  J R Bonham
Journal:  Clin Biochem       Date:  2014-05-20       Impact factor: 3.281

Review 6.  Inborn errors of metabolism: iron.

Authors:  M Worwood
Journal:  Br Med Bull       Date:  1999       Impact factor: 4.291

Review 7.  Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review.

Authors:  Clara D M van Karnebeek; Sylvia Stockler
Journal:  Mol Genet Metab       Date:  2011-11-30       Impact factor: 4.797

8.  PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels.

Authors:  Kazuyuki Nakamura; Hitoshi Osaka; Yoshiko Murakami; Rie Anzai; Kiyomi Nishiyama; Hirofumi Kodera; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Taroh Kinoshita; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Epilepsia       Date:  2014-01-13       Impact factor: 5.864

Review 9.  Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: A case report and literature review.

Authors:  Minguang Chen; Jieqiu Zhuang; JianHuan Yang; Dexuan Wang; Qing Yang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

Review 10.  Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review.

Authors:  Emma Graham; Jessica Lee; Magda Price; Maja Tarailo-Graovac; Allison Matthews; Udo Engelke; Jeffrey Tang; Leo A J Kluijtmans; Ron A Wevers; Wyeth W Wasserman; Clara D M van Karnebeek; Sara Mostafavi
Journal:  J Inherit Metab Dis       Date:  2018-05-02       Impact factor: 4.982

View more
  1 in total

1.  High levels of blood glutamic acid and ornithine in children with intellectual disability.

Authors:  Muhammad Wasim; Haq Nawaz Khan; Hina Ayesha; Abdul Tawab; Fazal E Habib; Muhammad Rafique Asi; Mazhar Iqbal; Fazli Rabbi Awan
Journal:  Int J Dev Disabil       Date:  2020-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.